BioSpace News Archive

Business

Advantech Connect Online Partner Conference to Promote Edge-to-Cloud Partnerships and AIoT Solutions for Smart City Services

Advantech (stock code: 2395), a leading provider of advanced IoT intelligence systems, is excited to launch its Advantech Connect Online Partner Conference, an online partner conference for global partners, focusing on the theme “Edge-to-Cloud Partnerships Enable Smart City Services with AIoT.”

April 21, 2021
·
5 min read
Seegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last year

Seegene Inc. (KQ 096530), a leading biotechnology firm said it began supplying its COVID-19 diagnostic tests worth 16,209,150 GBP to Scotland under a public procurement agreement, the largest diagnostic volume seen in that r

April 21, 2021
·
3 min read
Deals

Zymergen Announces Pricing of Upsized Initial Public Offering - Apr 22, 2021

Zymergen Inc., one of the world’s foremost biofacturing companies, announced the pricing of its initial public offering of 16,130,000 shares of its common stock at a public offering price of $31.00 per share.

April 21, 2021
·
2 min read
Deals

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Apr 22, 2021

CTI BioPharma Corp. announced that the Compensation Committee of its Board of Directors granted equity awards to two new employees as equity inducement awards outside of the Company’s Amended and Restated 2017 Equity Incentive Plan and material to the employees’ acceptance of employment with the company.

April 21, 2021
·
1 min read
BioMark Announces Exercise of Warrants and Gain DTC Eligibility for Its Common Shares

The gross proceeds to the company from the exercise of the warrants are expected to be approximately $400,000.00.

April 21, 2021
·
3 min read
Business

BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2021

BIOQUAL, Inc. announced details to the fiscal year 2021 unaudited third quarter results

April 21, 2021
·
1 min read
BioForest

Prevencio Announces Laboratory Commercialization Partnership with Atlas Genomics Incorporating Microsoft’s AI-computing Cloud

Prevencio, Inc. today announces an Agreement with Atlas Genomics to commercially launch its highly accurate, AI-driven HART blood tests for heart disease and risk of heart attack, stroke, and cardiovascular death. The HART blood tests are now available and can be ordered through your physician.

April 21, 2021
·
4 min read
Lone Star Bio

Service Corporation International Announces Schedule For Its First Quarter 2021 Earnings Release and Conference Call

Service Corporation International (NYSE: SCI) announced it expects to issue a press release with financial results for the first quarter 2021 on Monday, May 3 , 2021. A conference call will be hosted by SCI Management on Tuesday, May 4 , 2021. Details of the conference call are as follows:

April 21, 2021
·
1 min read
Biotech Beach

Solace Therapeutics Announces that Tri Valley Urology Enrolls First Patient in US Pivotal Clinical Trial, using New Office-Based Treatment for Female Stress Urinary Incontinence(SUI).

Tri Valley Urology, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure.

April 21, 2021
·
2 min read
Drug Development

Istari Oncology Announces Publication of Phase 1 Data Showing PVSRIPO Immunotherapy Leads to Objective Responses in Patients with Treatment-Refractory Melanoma

Istari Oncology, Inc., a clinical-stage biotechnology company, today announced the publication of “A phase 1 trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma” in the BMJ’s Journal for ImmunoTherapy of Cancer.

April 21, 2021
·
5 min read